We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Syncona Limited | LSE:SYNC | London | Ordinary Share | GG00B8P59C08 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 122.00 | 121.20 | 122.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -39.79M | -56.02M | -0.0840 | -14.52 | 813.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/8/2018 22:02 | Arix, management taking £5m pa in COMP is a put off what is the syncona management remuneration ? The market clearly much prefers syncona, i agree and also have a minor arix holding, just out of the outrageous drawings | kristini2 | |
17/8/2018 18:33 | Rambutan.I feel Arix might be a good trade but I am fully committed with Syncona.Thanks all the same. | ltinvestor | |
17/8/2018 18:17 | Itinvestor, but ARIX mkt cap is £215m whereas SYNC is £1.9bn... In any case, I won't mention again on this thread, it was just a heads up to a similar style company. | rambutan2 | |
17/8/2018 17:16 | I looked at Arix after a mention on this thread but quickly concluded that it wouldn't add much incremental value over and above Syncona and I much prefer Syncona's business model. That said, if I had some spare cash Arix looks ripe for a spreadbet buying on the expectation of a bounce back. Risky though, as is the way of spreadbetting. | audigger | |
17/8/2018 16:43 | Arix own 8% of Autolus and Syncona own 38%. | ltinvestor | |
17/8/2018 15:32 | Thanks rambutan I’ll have another look. Interesting area. I like private equity type companies so am also invested in Melrose and Burford. | brexitplus | |
17/8/2018 15:24 | brexitplus, I agree that SYNC is more classy, and I've held onto most of my shares. But ARIX does hold some interesting stakes, has over £100m cash and is approaching a 20% discount. An rns revealed an overhang has been cleared today, which explains why the share price has rather drooped recently. Could offer a trade, if nothing else. | rambutan2 | |
17/8/2018 15:11 | Autolus up again today. I’ve looked at Arix but I’m not as impressed with it as I am with Syncona. Odd Arix going down when Syncona going down. Perhaps investors switching. For my part, I think Syncona has a better team, structure with no debt, and portfolio. Still it is trading at a big premium, but I think has a faster route to selling companies. | brexitplus | |
17/8/2018 14:27 | If it's AUTL exposure one is after, then ARIX currently offers the biggest hit. Its £74m stake covers a third of ARIX's mkt cap. Add in a big slug of cash and a bunch of other interesting early stagers. In any case, it tempted me in recently and is worth a look for folks interested in the sector. Imho. | rambutan2 | |
17/8/2018 07:40 | Yes, finished at $30.4 but was as high as $31.85. | brexitplus | |
17/8/2018 07:09 | Autolus up 6.67% at session end on Nasdaq. | ltinvestor | |
16/8/2018 18:31 | Looking to breakout above 300 which would be nice! | audigger | |
16/8/2018 09:37 | The premium before the trading update was 50%. It may return there on the £ weakness. Autolus good again yesterday. Highest ever share price | brexitplus | |
16/8/2018 09:25 | Aiming at 300! | audigger | |
16/8/2018 09:17 | Flying again today. | brexitplus | |
16/8/2018 09:12 | Largest holding in my portfolio, I continue to add. | luxaeterna1 | |
16/8/2018 09:04 | .... and mine Alan! | ltinvestor | |
15/8/2018 18:42 | Apart from BBY, this is the only riser in my portfolio today. | alan@bj | |
15/8/2018 18:09 | Like it. Wish I'd topped up now! | audigger | |
15/8/2018 11:26 | Autolus hitting new close of day high yesterday may have influenced. It’s very much a lock in the bottom drawer stock with numerous long term blue sky prospects. As such I imagine shares are tightly held, and any demand will squeeze share price higher. | acuere | |
15/8/2018 11:03 | Hard to say, the US clinical trials were due to initiate in H2 2018 for Autolus on DLBCL, ALL and Multiple Myeloma cancer classes. A lot of chatter over that perhaps? | luxaeterna1 | |
15/8/2018 09:58 | Audigger 270p. Not sure why the rise though. Any ideas? | brexitplus | |
09/8/2018 16:22 | Autolus with just one success will be snapped up at a big premium. I topped up this morning on the trading update. | brexitplus | |
09/8/2018 11:01 | Jeebus, I had no idea Autolus were in pre-clinical testing on 15 separate cancer conditions. | luxaeterna1 | |
09/8/2018 07:56 | Excellent trading update. First class team. | brexitplus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions